Lupin Limited: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''Lupin Limited''' is a multinational pharmaceutical company based in [[Mumbai]], [[India]]. It is one of the largest generic pharmaceutical manufacturers in the world, and one of the leading innovators in the field of [[pharmacology]].
== Lupin Limited ==
 
[[File:The_Lupin_Logo.svg|thumb|right|Lupin Limited Logo]]
 
'''Lupin Limited''' is a multinational pharmaceutical company based in [[Mumbai]], [[India]]. It is one of the largest generic pharmaceutical companies in the world, known for its wide range of products and significant contributions to the healthcare industry.


== History ==
== History ==
Lupin Limited was founded in 1968 by [[Desh Bandhu Gupta]], a former professor at the Birla Institute of Technology and Science. The company was named after the Lupin flower because of its inherent qualities and what it personifies and stands for – nourishment and growth.
Lupin Limited was founded in 1968 by Dr. Desh Bandhu Gupta. The company started as a small vitamin company and has grown into a global pharmaceutical giant. Over the years, Lupin has expanded its operations across the globe, establishing a strong presence in the [[United States]], [[Europe]], [[Japan]], and other key markets.
 
== Products and Services ==
Lupin Limited specializes in the development, manufacture, and sale of a wide range of pharmaceutical products. These include:


== Business Operations ==
* '''Generic Drugs''': Lupin is a leading producer of generic medications, which are bioequivalent to branded drugs but are sold at a lower cost.
Lupin Limited operates in the [[Pharmaceutical industry|pharmaceutical]] sector, with a significant presence in the fields of [[Cardiovascular disease|Cardiovascular]], [[Diabetology]], [[Asthma]], [[Pediatric]], [[Central Nervous System]], [[Gastro Intestinal]], [[Anti-Infective]] and [[Nonsteroidal anti-inflammatory drug|NSAIDs]] among others. The company's key focus areas include [[Paediatrics]], [[Cardiovascular]], [[Anti-diabetics]], [[Anti-asthma]] and [[Anti-infective]].
* '''Branded Formulations''': The company also markets branded formulations in various therapeutic areas such as [[cardiology]], [[diabetology]], [[asthma]], [[pediatrics]], [[central nervous system]], [[gastroenterology]], [[anti-infectives]], and [[nonsteroidal anti-inflammatory drugs|NSAIDs]].
* '''Active Pharmaceutical Ingredients (APIs)''': Lupin manufactures APIs for use in its own formulations and for sale to other pharmaceutical companies.


== Research and Development ==
== Research and Development ==
Lupin Limited has a significant presence in the area of [[Drug discovery|drug discovery]] and [[Drug development|development]]. The company's research and development (R&D) efforts are focused on developing new chemical entities (NCEs) and advanced drug delivery systems. Lupin's R&D activities are spread across various locations in India and abroad, including the USA and Japan.
Lupin Limited invests significantly in [[research and development]] (R&D) to innovate and improve its product offerings. The company operates several R&D centers across the world, focusing on the development of new drug formulations, novel drug delivery systems, and the synthesis of complex APIs.


== Global Presence ==
== Global Presence ==
Lupin Limited has a global footprint with presence in over 100 countries. The company has manufacturing sites spread across India, the USA, Japan, and Brazil. Lupin's global presence includes a network of subsidiaries, joint ventures, and alliances.
Lupin has a strong international presence, with manufacturing facilities and offices in multiple countries. The company has established subsidiaries in the United States, [[Brazil]], [[Mexico]], [[Australia]], [[South Africa]], and several European countries. This global footprint allows Lupin to effectively serve diverse markets and meet the healthcare needs of millions of patients worldwide.
 
== Corporate Social Responsibility ==
Lupin Limited is committed to corporate social responsibility (CSR) and actively engages in initiatives aimed at improving healthcare access, education, and environmental sustainability. The Lupin Foundation, the company's CSR arm, implements various programs to support community development and enhance the quality of life for underprivileged populations.


== See Also ==
== See also ==
* [[Pharmaceutical industry in India]]
* [[Pharmaceutical industry in India]]
* [[List of pharmaceutical companies]]
* [[Generic drug]]
* [[Active pharmaceutical ingredient]]


== References ==
== Related pages ==
<references />
* [[Sun Pharmaceutical]]
 
* [[Dr. Reddy's Laboratories]]
== External Links ==
* [[Cipla]]
* [http://www.lupin.com Official Website]


[[Category:Pharmaceutical companies of India]]
[[Category:Pharmaceutical companies of India]]
[[Category:Companies based in Mumbai]]
[[Category:Companies based in Mumbai]]
[[Category:Companies listed on the Bombay Stock Exchange]]
[[Category:Companies established in 1968]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Indian brands]]
[[Category:Pharmaceutical companies established in 1968]]
[[Category:1968 establishments in Maharashtra]]
 
{{pharmacology-stub}}

Latest revision as of 11:58, 15 February 2025

Lupin Limited[edit]

File:The Lupin Logo.svg
Lupin Limited Logo

Lupin Limited is a multinational pharmaceutical company based in Mumbai, India. It is one of the largest generic pharmaceutical companies in the world, known for its wide range of products and significant contributions to the healthcare industry.

History[edit]

Lupin Limited was founded in 1968 by Dr. Desh Bandhu Gupta. The company started as a small vitamin company and has grown into a global pharmaceutical giant. Over the years, Lupin has expanded its operations across the globe, establishing a strong presence in the United States, Europe, Japan, and other key markets.

Products and Services[edit]

Lupin Limited specializes in the development, manufacture, and sale of a wide range of pharmaceutical products. These include:

  • Generic Drugs: Lupin is a leading producer of generic medications, which are bioequivalent to branded drugs but are sold at a lower cost.
  • Branded Formulations: The company also markets branded formulations in various therapeutic areas such as cardiology, diabetology, asthma, pediatrics, central nervous system, gastroenterology, anti-infectives, and NSAIDs.
  • Active Pharmaceutical Ingredients (APIs): Lupin manufactures APIs for use in its own formulations and for sale to other pharmaceutical companies.

Research and Development[edit]

Lupin Limited invests significantly in research and development (R&D) to innovate and improve its product offerings. The company operates several R&D centers across the world, focusing on the development of new drug formulations, novel drug delivery systems, and the synthesis of complex APIs.

Global Presence[edit]

Lupin has a strong international presence, with manufacturing facilities and offices in multiple countries. The company has established subsidiaries in the United States, Brazil, Mexico, Australia, South Africa, and several European countries. This global footprint allows Lupin to effectively serve diverse markets and meet the healthcare needs of millions of patients worldwide.

Corporate Social Responsibility[edit]

Lupin Limited is committed to corporate social responsibility (CSR) and actively engages in initiatives aimed at improving healthcare access, education, and environmental sustainability. The Lupin Foundation, the company's CSR arm, implements various programs to support community development and enhance the quality of life for underprivileged populations.

See also[edit]

Related pages[edit]